Beprosone

Beprosone

betamethasone

Manufacturer:

Hoe Pharma

Distributor:

Zuellig Pharma

Marketer:

Taisho Pharmaceutical
Concise Prescribing Info
Contents
Betamethasone dipropionate
Indications/Uses
Relief of inflammatory manifestations of corticosteroids-responsive dermatoses.
Dosage/Direction for Use
Apply to the affected skin areas once or bd.
Contraindications
Hypersensitivity to betamethasone dipropionate or other corticosteroids.
Special Precautions
Discontinue use if irritation, sensitivity or other reaction develops. Prolonged treatment, when treating extensive BSA, using occlusive dressing & in childn. Pregnancy & lactation.
Adverse Reactions
Burning sensation, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, maceration of the skin, secondary infection, skin atrophy, striae & miliaria.
ATC Classification
D07AC01 - betamethasone ; Belongs to the class of potent (group III) corticosteroids. Used in the treatment of dermatological diseases.
Additional Information
Exemptions granted for limited sale and supply without prescription (with effect from 31 March 2016):
As a topical preparation (as valerate or dipropionate salt) as a single agent not exceeding 0.1%
Indication: Symptomatic relief of inflammatory skin or scalp disorders such as dermatitis and eczema
Maximum daily dose: Apply to affected areas twice daily
Maximum supply: 15 g for cream/ointment/gel; 30 mL for topical solution
Minimum age: 18 years
Presentation/Packing
Form
Beprosone oint 0.064 %
Packing/Price
15 g x 1's
Form
Beprosone cream 0.064%
Packing/Price
15 g x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in